310 related articles for article (PubMed ID: 34637332)
1. Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD.
Hess CN; Debus ES; Nehler MR; Anand SS; Patel MR; Szarek M; Capell WH; Hsia J; Beckman JA; Brodmann M; Diaz R; Habertheuer P; Leeper NJ; Powell RJ; Sillesen H; Muehlhofer E; Berkowitz SD; Haskell LP; Bauersachs RM; Bonaca MP
Circulation; 2021 Dec; 144(23):1831-1841. PubMed ID: 34637332
[TBL] [Abstract][Full Text] [Related]
2. Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD.
Rymer J; Anand SS; Sebastian Debus E; Haskell LP; Hess CN; Jones WS; Muehlhofer E; Berkowitz SD; Bauersachs RM; Bonaca MP; Patel MR
Circulation; 2023 Dec; 148(24):1919-1928. PubMed ID: 37850397
[TBL] [Abstract][Full Text] [Related]
3. Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial.
Debus ES; Nehler MR; Govsyeyev N; Bauersachs RM; Anand SS; Patel MR; Fanelli F; Capell WH; Brackin T; Hinterreiter F; Krievins D; Nault P; Piffaretti G; Svetlikov A; Jaeger N; Hess CN; Sillesen HH; Conte M; Mills J; Muehlhofer E; Haskell LP; Berkowitz SD; Hiatt WR; Bonaca MP
Circulation; 2021 Oct; 144(14):1104-1116. PubMed ID: 34380322
[TBL] [Abstract][Full Text] [Related]
4. Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety.
Hiatt WR; Bonaca MP; Patel MR; Nehler MR; Debus ES; Anand SS; Capell WH; Brackin T; Jaeger N; Hess CN; Pap AF; Berkowitz SD; Muehlhofer E; Haskell L; Brasil D; Madaric J; Sillesen H; Szalay D; Bauersachs R
Circulation; 2020 Dec; 142(23):2219-2230. PubMed ID: 33138628
[TBL] [Abstract][Full Text] [Related]
5. Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD Trial.
Bauersachs RM; Szarek M; Brodmann M; Gudz I; Debus ES; Nehler MR; Anand SS; Patel MR; Hess CN; Capell WH; Rogers K; Muehlhofer E; Haskell LP; Berkowitz SD; Hiatt WR; Bonaca MP;
J Am Coll Cardiol; 2021 Jul; 78(4):317-326. PubMed ID: 34010631
[TBL] [Abstract][Full Text] [Related]
6. Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits.
Govsyeyev N; Nehler M; Conte MS; Debus S; Chung J; Dorigo W; Gudz I; Krievins D; Mills J; Moll F; Norgren L; Piffaretti G; Powell R; Szalay D; Sillesen H; Wohlauer M; Szarek M; Bauersachs RM; Anand SS; Patel MR; Capell WH; Jaeger N; Hess CN; Muehlhofer E; Haskell LP; Berkowitz SD; Bonaca MP
J Vasc Surg; 2023 Apr; 77(4):1107-1118.e2. PubMed ID: 36470531
[TBL] [Abstract][Full Text] [Related]
7. Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization.
Hess CN; Szarek M; Anand SS; Bauersachs RM; Patel MR; Debus ES; Nehler MR; Capell WH; Beckman JA; Piazza G; Henkin S; Bura-Rivière A; Lawall H; Roztocil K; Hsia J; Muehlhofer E; Berkowitz SD; Haskell LP; Bonaca MP
JAMA Netw Open; 2022 Jun; 5(6):e2215580. PubMed ID: 35731517
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a "CASPAR like" outcome from VOYAGER PAD.
Bonaca MP; Szarek M; Debus ES; Nehler MR; Patel MR; Anand SS; Muehlhofer E; Berkowitz SD; Haskell LP; Bauersachs RM
Clin Cardiol; 2022 Dec; 45(12):1143-1146. PubMed ID: 36251249
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD).
Capell WH; Bonaca MP; Nehler MR; Chen E; Kittelson JM; Anand SS; Berkowitz SD; Debus ES; Fanelli F; Haskell L; Patel MR; Bauersachs R; Hiatt WR
Am Heart J; 2018 May; 199():83-91. PubMed ID: 29754671
[TBL] [Abstract][Full Text] [Related]
10. Sex-Based Differences in Outcomes Following Peripheral Artery Revascularization: Insights From VOYAGER PAD.
Hess CN; Baumgartner I; Anand SS; Nehler MR; Patel MR; Debus ES; Szarek M; Capell W; Muehlhofer E; Berkowitz SD; Haskell LP; Bauersachs RM; Bonaca MP; Hsia J
J Am Heart Assoc; 2022 Jun; 11(12):e024655. PubMed ID: 35699170
[TBL] [Abstract][Full Text] [Related]
11. Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PAD.
Hess CN; Patel MR; Bauersachs RM; Anand SS; Debus ES; Nehler MR; Fanelli F; Yeh RW; Secemsky EA; Beckman JA; Mauri L; Govsyeyev N; Capell WH; Brackin T; Berkowitz SD; Muehlhofer E; Haskell LP; Hiatt WR; Bonaca MP
J Am Coll Cardiol; 2021 Nov; 78(18):1768-1778. PubMed ID: 34711335
[TBL] [Abstract][Full Text] [Related]
12. Acute Limb Ischemia in Peripheral Artery Disease.
Hess CN; Huang Z; Patel MR; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Held P; Jones WS; Katona B; Mahaffey KW; Norgren L; Rockhold FW; Hiatt WR
Circulation; 2019 Aug; 140(7):556-565. PubMed ID: 31238713
[TBL] [Abstract][Full Text] [Related]
13. Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone.
Berkowitz SD; Bauersachs RM; Szarek M; Nehler MR; Debus ES; Patel MR; Anand SS; Capell WH; Hess CN; Hsia J; Leeper NJ; Brasil D; Mátyás L; Diaz R; Brodmann M; Muehlhofer E; Haskell LP; Bonaca MP
J Thromb Haemost; 2022 May; 20(5):1193-1205. PubMed ID: 35170216
[TBL] [Abstract][Full Text] [Related]
14. Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial.
Krantz MJ; Debus SE; Hsia J; Patel MR; Anand SS; Nehler MR; Hess CN; Capell WH; Bracken T; Szarek M; Mátyás L; Krievins DK; Nault P; Stefanov S; Haskell LP; Berkowitz SD; Muehlhofer E; Hiatt WR; Bauersachs RM; Bonaca MP
Eur Heart J; 2021 Oct; 42(39):4040-4048. PubMed ID: 34430972
[TBL] [Abstract][Full Text] [Related]
15. Rivaroxaban in Peripheral Artery Disease after Revascularization.
Bonaca MP; Bauersachs RM; Anand SS; Debus ES; Nehler MR; Patel MR; Fanelli F; Capell WH; Diao L; Jaeger N; Hess CN; Pap AF; Kittelson JM; Gudz I; Mátyás L; Krievins DK; Diaz R; Brodmann M; Muehlhofer E; Haskell LP; Berkowitz SD; Hiatt WR
N Engl J Med; 2020 May; 382(21):1994-2004. PubMed ID: 32222135
[TBL] [Abstract][Full Text] [Related]
16. Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease: The COMPASS Trial.
Anand SS; Caron F; Eikelboom JW; Bosch J; Dyal L; Aboyans V; Abola MT; Branch KRH; Keltai K; Bhatt DL; Verhamme P; Fox KAA; Cook-Bruns N; Lanius V; Connolly SJ; Yusuf S
J Am Coll Cardiol; 2018 May; 71(20):2306-2315. PubMed ID: 29540326
[TBL] [Abstract][Full Text] [Related]
17. Comparison of rivaroxaban-based dual antithrombotic and antiplatelet therapies for symptomatic patients with lower-extremity peripheral artery disease post-revascularization: a retrospective cohort study.
Ji Y; Wang B; Wu G; Zhang Y; Wang Q; Zhou M
Ther Adv Chronic Dis; 2023; 14():20406223231213262. PubMed ID: 38085917
[TBL] [Abstract][Full Text] [Related]
18. Low-dose rivaroxaban and aspirin among patients with peripheral artery disease: a meta-analysis of the COMPASS and VOYAGER trials.
Anand SS; Hiatt W; Dyal L; Bauersachs R; Berkowitz SD; Branch KRH; Debus S; Fox KAA; Liang Y; Muehlhofer E; Nehler M; Haskell LP; Patel M; Szarek M; Yusuf S; Eikelboom J; Bonaca MP
Eur J Prev Cardiol; 2022 May; 29(5):e181-e189. PubMed ID: 34463737
[TBL] [Abstract][Full Text] [Related]
19. Editor's Choice - External Applicability of the COMPASS and VOYAGER-PAD Trials on Patients with Symptomatic Lower Extremity Artery Disease in France: The COPART Registry.
Lapébie FX; Aboyans V; Lacroix P; Constans J; Boulon C; Messas E; Ferrières J; Bongard V; Bura-Rivière A
Eur J Vasc Endovasc Surg; 2021 Sep; 62(3):439-449. PubMed ID: 34330647
[TBL] [Abstract][Full Text] [Related]
20. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
Anand SS; Bosch J; Eikelboom JW; Connolly SJ; Diaz R; Widimsky P; Aboyans V; Alings M; Kakkar AK; Keltai K; Maggioni AP; Lewis BS; Störk S; Zhu J; Lopez-Jaramillo P; O'Donnell M; Commerford PJ; Vinereanu D; Pogosova N; Ryden L; Fox KAA; Bhatt DL; Misselwitz F; Varigos JD; Vanassche T; Avezum AA; Chen E; Branch K; Leong DP; Bangdiwala SI; Hart RG; Yusuf S;
Lancet; 2018 Jan; 391(10117):219-229. PubMed ID: 29132880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
